Inflammatory bowel diseases and Parkinson's disease
Open accessThe DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
The etiology of Parkinson’s disease (PD) is multifactorial, with genetics, aging, and environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites, and degeneration of substantia nigra dopamine neurons are the pathological hallmarks of PD. Inflammatory responses manifested by glial reactions, T cell infiltration, and increased expression of inflammatory cytokines, as well as other toxic mediators derived from activated glial cells, are currently recognized as prominent features of PD. Experimental, clinical and epidemiological data suggest that intestinal inflammation contributes to the pathogenesis of PD, and the increasing number of studies suggests that the condition may start in the gastrointestinal system years before any motor symptoms develop. Patients with inflammatory bowel disease (IBD) have a higher risk of developing PD compared with non-IBD individuals. Gene association study has found a genetic link between IBD and PD, and an evidence from animal studies suggests that gut inflammation, similar to that observed in IBD, may induce loss of dopaminergic neurons. Based on preclinical models of PD, it is suggested that the enteric microbiome changes early in PD, and gut infections trigger α-synuclein release and aggregation. In this paper, the possible link between IBD and PD is reviewed based on the available literature. Given the potentially critical role of gastrointestinal pathology in PD pathogenesis, there is reason to suspect that IBD or its treatments may impact PD risk. Thus, clinicians should be aware of PD symptoms in IBD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies have shown that patients with inflammatory bowel diseases have a higher risk of Parkinson's disease.”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
The cited source says what the claim attributes to it.
In the citing paper
“In autoimmune conditions, peripheral inflammation caused by gut inflammation may trigger a-synuclein aggregation, increasing the permeability of intestinal tract and BBB and leading to neuroinflammation.98”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, inflammatory bowel diseases and Parkinson's disease share some common genetic factors.98”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“a pathway to spread the pathological protein to the 636 brain according to the Braak’s theory [5, 131].”
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“In fact, neurochemical and behavioral effects were not present in vagotomized mice, identifying the vagus as the major modulatory constitutive communication pathway between microbiota and the brain [128].”
BackgroundGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712 · cited 1×
“The major 92 symptoms of UC are diarrhea, rectal bleeding, tenes93 mus, passage of mucus, and crampy abdominal pain 94 [20].”
BackgroundCytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Kim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · cited 1×
“In yet another animal study pathological -syn preformed fibrils were injected into the duodenal and pyloric muscularis layer causing retrograde, polysynaptic spreading of pathology into the brain which was further hampered by truncal vagotomy [132].”
BackgroundBraak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1343-6 · Cited by 925
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Vagotomy and subsequent risk of Parkinson's disease
Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology · doi:10.1002/ana.24448 · Cited by 806
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 749
Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
(2007) · YUHSpace (Yonsei University Medical Library) · doi:10.1016/s1474 · Cited by 641
A meta-analysis of the role of smoking in inflammatory bowel disease
Calkins, B. M. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01536701 · Cited by 637
Colonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · cited 3×
“It was concluded that the mRNA-expression levels of pro-inflammatory cytokines were significantly elevated in the ascending colon of PD patients [16].”
BackgroundInfluentialPathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., MacPhee, G., Brown, R. G., Naidu, Y., Clayton, L., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 554
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · cited 1×
“PD mice show a strong immune response in the gut [95], and colonic biopsies of PD patients show evidence of a structural dysfunction of the intestinal barrier, reinforcing the idea of a role of the GI tract in the initiation and/or the progression of the disease [96, 97].”
BackgroundThe Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study)
Pont‐Sunyer, C., Hotter, A., Gaig, C., Seppi, K., Compta, Y., Katzenschlager, R., Mas, N., Hofeneder, D., Brücke, T., Bayés, A., et al. (2015) · Movement Disorders · doi:10.1002/mds.26077 · Cited by 511
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases
Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25020 · Cited by 464 · cited 1×
“Accord39 ingly, -syn immunostaining has been showed in 40 distal colon tissue samples removed 2 to 5 years 41 before the first reported symptom of PD in patients 42 experiencing constipation prior to PD onset [8].”
BackgroundLRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463
Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study
Liu, B., Fang, F., Pedersen, N. L., Tillander, A., Ludvigsson, J. F., Ekbom, A., Svenningsson, P., Chen, H., & Wirdefeldt, K. (2017) · Neurology · doi:10.1212/wnl.0000000000003961 · Cited by 447
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Gardet, A., Benita, Y., Li, C., Sands, B. E., Ballester, I., Stevens, C., Korzenik, J. R., Rioux, J. D., Daly, M. J., Xavier, R. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000548 · Cited by 415
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405
Peter, I., Dubinsky, M., Bressman, S., Park, A., Lu, C., Chen, N., & Wang, A. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0605 · Cited by 386
Hui, K. Y., Fernandez-Hernandez, H., Hu, J., Schaffner, A., Pankratz, N., Hsu, N.-Y., Chuang, L.-S., Carmi, S., Villaverde, N., Li, X., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7795 · Cited by 384 · cited 1×
“56 × 10–9), after exome sequencing 127 followed by array-based genotyping of 2066 cases 128 and 3633 controls in the Ashkenazi Jewish population 129 [32].”
MethodGastrointestinal symptoms in Parkinson's disease
Edwards, L. L., Pfeiffer, R. F., Quigley, E. M. M., Hofman, R., & Balluff, M. (1991) · Movement Disorders · doi:10.1002/mds.870060211 · Cited by 375
Liu, Z., Lee, J., Krummey, S., Lu, W., Cai, H., & Lenardo, M. J. (2011) · Nature Immunology · doi:10.1038/ni.2113 · Cited by 361
Multiple organ involvement by alpha-synuclein pathology in lewy body disorders
Gelpi, E., Navarro‐Otano, J., Tolosa, E., Gaig, C., Compta, Y., Rey, M. J., Martí, M. J., Hernández, I., Valldeoriola, F., Reñé, R., et al. (2014) · Movement Disorders · doi:10.1002/mds.25776 · Cited by 361
Genome-wide pleiotropy between Parkinson disease and autoimmune diseases
Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0469 · Cited by 352
Ross, O. A., Soto-Ortolaza, A. I., Heckman, M. G., Aasly, J. O., Abahuni, N., Annesi, G., Bacon, J. A., Bardien, S., Bozi, M., Brice, A., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70175-2 · Cited by 336
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 324
Gut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318
Schwiertz, A., Spiegel, J., Dillmann, U., Grundmann, D., Bürmann, J., Faßbender, K., Schäfer, K.-H., & Unger, M. M. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.022 · Cited by 318
Villumsen, M., Aznar, S., Pakkenberg, B., Jess, T., & Brudek, T. (2019) · Gut · doi:10.1136/gutjnl-2017-315666 · Cited by 314
Self-citationTriggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
Johnson, M. E., Stecher, B., Labrie, V., Brundin, L., & Brundin, P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.09.007 · Cited by 310
Van Den Berge, N., Ferreira, N., Gram, H., Mikkelsen, T. W., Alstrup, A. K. O., Casadei, N., Tsung-Pin, P., Riess, O., Nyengaard, J. R., Tamgüney, G., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02040-w · Cited by 300 · cited 2×
“A very recent study provides an immunohistochemical evidence for propagation of initially localized enteric -syn pathology through the autonomic nervous system to the brain in a transgenic rodent model [130].”
BackgroundChanges of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
Ford, A. C., Achkar, J.-P., Khan, K. J., Kane, S. V., Talley, N. J., Marshall, J. K., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.67 · Cited by 295
Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
Clairembault, T., Leclair-Visonneau, L., Coron, E., Bourreille, A., Le Dily, S., Vavasseur, F., Heymann, M.-F., Neunlist, M., & Derkinderen, P. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0196-0 · Cited by 291
A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity
Stolzenberg, E., Berry, D., Yang, D., Lee, E. Y., Kroemer, A., Kaufman, S., Wong, G. C. L., Oppenheim, J. J., Sen, S., Fishbein, T., et al. (2017) · Journal of Innate Immunity · doi:10.1159/000477990 · Cited by 284
Hakimi, M., Selvanantham, T., Swinton, E., Padmore, R. F., Tong, Y., Kabbach, G., Venderova, K., Girardin, S. E., Bulman, D. E., Scherzer, C. R., et al. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0653-2 · Cited by 283
The vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 279
Genetic Analysis of Pathways to Parkinson Disease
Hardy, J. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.014 · Cited by 274
Heliö, T., Halme, L., Lappalainen, M., Fodstad, H., Paavola-Sakki, P., Turunen, U., Färkkilä, M., Krusius, T., & Kontula, K. (2003) · Gut · doi:10.1136/gut.52.4.558 · Cited by 270
Gillardon, F., Schmid, R., & Draheim, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.001 · Cited by 222
Villarán, R. F., Espinosa‐Oliva, A. M., Sarmiento, M., De Pablos, R. M., Argüelles, S., Delgado‐Cortés, M. J., Sobrino, V., Van Rooijen, N., Venero, J. L., Herrera, A. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06879.x · Cited by 214
Enteric glia: the most alimentary of all glia
Grubišić, V., & Gulbransen, B. D. (2017) · The Journal of Physiology · doi:10.1113/jp271021 · Cited by 207
Commensal bacteria direct selective cargo sorting to promote symbiosis
Zhang, Q., Pan, Y., Yan, R., Zeng, B., Wang, H., Zhang, X., Li, W., Wei, H., & Liu, Z. (2015) · Nature Immunology · doi:10.1038/ni.3233 · Cited by 206
Bowel movement frequency in late‐life and incidental Lewy bodies
Abbott, R. D., Ross, G. W., Petrovitch, H., Tanner, C. M., Davis, D. G., Masaki, K. H., Launer, L. J., Curb, J. D., & White, L. R. (2007) · Movement Disorders · doi:10.1002/mds.21560 · Cited by 203
Lin, J.-C., Lin, C.-S., Hsu, C.-W., Lin, C.-L., & Kao, C.-H. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000735 · Cited by 202
Fehrenbacher, J. C., Vasko, M. R., & Duarte, D. B. (2012) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0504s56 · Cited by 201
Manfredsson, F. P., Luk, K. C., Benskey, M. J., Gezer, A., Garcia, J., Kuhn, N. C., Sandoval, I. M., Patterson, J. R., O'Mara, A., Yonkers, R., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.008 · Cited by 199
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease
Houser, M. C., Chang, J., Factor, S. A., Molho, E. S., Zabetian, C. P., Hill‐Burns, E. M., Payami, H., Hertzberg, V. S., & Tansey, M. G. (2018) · Movement Disorders · doi:10.1002/mds.27326 · Cited by 199
The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease
Gaenslen, A., Swid, I., Liepelt‐Scarfone, I., Godau, J., & Berg, D. (2011) · Movement Disorders · doi:10.1002/mds.23499 · Cited by 198
Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey
Siddiqui, M. F., Rast, S., Lynn, M. J., Auchus, A. P., & Pfeiffer, R. F. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00052-9 · Cited by 195
Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation
Thévenet, J., Pescini Gobert, R., Hooft van Huijsduijnen, R., Wiessner, C., & Sagot, Y. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021519 · Cited by 189
Association between cigarette smoking and Parkinson’s disease: A meta-analysis
Li, X., Li, W., Liu, G., Shen, X., & Tang, Y. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.08.004 · Cited by 189
LRRK2 Expression in Normal and Pathologic Human Brain and in Human Cell Lines
Miklossy, J., Arai, T., Guo, J.-P., Klegeris, A., Yu, S., McGeer, E. G., & McGeer, P. L. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235121.98052.54 · Cited by 182
Does Parkinson’s disease start in the gut?
Lionnet, A., Leclair-Visonneau, L., Neunlist, M., Murayama, S., Takao, M., Adler, C. H., Derkinderen, P., & Beach, T. G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1777-8 · Cited by 176
Premotor Parkinson’s disease: Concepts and definitions
Siderowf, A., & Lang, A. E. (2012) · Movement Disorders · doi:10.1002/mds.24954 · Cited by 174
Inflammatory Bowel Disease and Parkinson’s Disease: A Nationwide Swedish Cohort Study
Weimers, P., Halfvarson, J., Sachs, M. C., Saunders-Pullman, R., Ludvigsson, J. F., Peter, I., Burisch, J., & Olén, O. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy190 · Cited by 174
Leal, M. C., Casabona, J. C., Puntel, M., & Pitossi, F. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00053 · Cited by 172
LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection
Liu, W., Liu, X., Li, Y., Zhao, J., Liu, Z., Hu, Z., Wang, Y., Yao, Y., Miller, A. W., Su, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170014 · Cited by 165
Starke Belege: Parkinson könnte im Verdauungstrakt beginnen
(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-113319 · Cited by 161
Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease
Ritz, B., Lee, P.-C., Lassen, C. F., & Arah, O. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000879 · Cited by 160
Ryan, K. J., White, C. C., Patel, K., Xu, J., Olah, M., Replogle, J. M., Frangieh, M., Cimpean, M., Winn, P., McHenry, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7635 · Cited by 159
Inflammatory Bowel Disease: Autoimmune or Immune‐mediated Pathogenesis?
Wen, Z., & Fiocchi, C. (2004) · Journal of Immunology Research · doi:10.1080/17402520400004201 · Cited by 158
Enteric glial cells and their role in the intestinal epithelial barrier
Yu, Y.-B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11273 · Cited by 155
Park, J., Paik, S. R., Jou, I., & Park, S. M. (2008) · Glia · doi:10.1002/glia.20691 · Cited by 150
Starring roles for astroglia in barrier pathologies of gut and brain
Savidge, T., Sofroniew, M., & Neunlist, M. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700600 · Cited by 142
Interleukin-6 expression and regulation in rat enteric glial cells
Rühl, A., Franzke, S., Collins, S. M., & Stremmel, W. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1163 · Cited by 140
Review article: ulcerative colitis, smoking and nicotine therapy
Lunney, P. C., & Leong, R. W. L. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12086 · Cited by 140
Expression pattern and localization of alpha-synuclein in the human enteric nervous system
Böttner, M., Zorenkov, D., Hellwig, I., Barrenschee, M., Harde, J., Fricke, T., Deuschl, G., Egberts, J.-H., Becker, T., Fritscher-Ravens, A., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.018 · Cited by 139
The risk of Parkinson’s disease in inflammatory bowel disease: A systematic review and meta-analysis
Zhu, F., Li, C., Gong, J., Zhu, W., Gu, L., & Li, N. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.017 · Cited by 136
Alpha‐synuclein in the appendiceal mucosa of neurologically intact subjects
Gray, M. T., Munoz, D. G., Gray, D. A., Schlossmacher, M. G., & Woulfe, J. M. (2014) · Movement Disorders · doi:10.1002/mds.25779 · Cited by 132
S100B protein in the gut: The evidence for enteroglial-sustained intestinal inflammation
Cirillo, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i10.1261 · Cited by 130
Gastrointestinal symptoms in parkinson disease: 18‐month follow‐up study
Edwards, L., Quigley, E. M. M., Hofman, R., & Pfeiffer, R. F. (1993) · Movement Disorders · doi:10.1002/mds.870080115 · Cited by 129
LRRK2 in Parkinson’s disease: genetic and clinical studies from patients
Kumari, U., & Tan, E. K. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07344.x · Cited by 125
Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease
Bardien, S., Lesage, S., Brice, A., & Carr, J. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.11.008 · Cited by 125
Garrido‐Gil, P., Rodriguez-Perez, A. I., Dominguez‐Meijide, A., Guerra, M. J., & Labandeira-García, J. L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0937-8 · Cited by 118
Enteric glial cells: New players in Parkinson's disease?
Clairembault, T., Leclair‐Visonneau, L., Neunlist, M., & Derkinderen, P. (2015) · Movement Disorders · doi:10.1002/mds.25979 · Cited by 117 · cited 1×
“Both IBD and PD have been associated with GI barrier dysfunction and furthermore, the GI symptoms that occur in PD might in part be caused by enteric glial dysfunction [96, 101].”
BackgroundExcess α-synuclein compromises phagocytosis in iPSC-derived macrophages
Haenseler, W., Zambon, F., Lee, H., Vowles, J., Rinaldi, F., Duggal, G., Houlden, H., Gwinn, K., Wray, S., Luk, K. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09362-3 · Cited by 117
Gut feelings about smoking and coffee in Parkinson's disease
Derkinderen, P., Shannon, K. M., & Brundin, P. (2014) · Movement Disorders · doi:10.1002/mds.25882 · Cited by 115
Kishimoto, Y., Zhu, W., Hosoda, W., Sen, J. M., & Mattson, M. P. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08539-5 · Cited by 114
Umeno, J., Asano, K., Matsushita, T., Matsumoto, T., Kiyohara, Y., Iida, M., Nakamura, Y., Kamatani, N., & Kubo, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21651 · Cited by 113
Cortical Inflammation is Increased in a DSS-Induced Colitis Mouse Model
Han, Y., Zhao, T., Cheng, X., Zhao, M., Gong, S.-H., Zhao, Y., Wu, H., Fan, M., & Zhu, L. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0288-5 · Cited by 107
Saleem, T., Higginson, I. J., Chaudhuri, К. R., Martin, A., Burman, R., & Leigh, P. N. (2012) · Palliative Medicine · doi:10.1177/0269216312465783 · Cited by 106
Does vagotomy reduce the risk of Parkinson's disease?
Tysnes, O., Kenborg, L., Herlofson, K., Steding‐Jessen, M., Horn, A., Olsen, J. H., & Reichmann, H. (2015) · Annals of Neurology · doi:10.1002/ana.24531 · Cited by 102
Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
Camacho-Soto, A., Gross, A., Searles Nielsen, S., Dey, N., & Racette, B. A. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.008 · Cited by 101
Hernández-Romero, M. C., Delgado-Cortés, M. J., Sarmiento, M., de Pablos, R. M., Espinosa-Oliva, A. M., Argüelles, S., Bández, M. J., Villarán, R. F., Mauriño, R., Santiago, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.018 · Cited by 100
Nonmotor symptoms of Parkinson's disease: Prevalence and awareness of patients and families
Cheon, S., Ha, M.-S., Park, M., & Kim, J. W. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.002 · Cited by 99
Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson’s Disease
Monfrini, E., & Fonzo, A. D. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_1 · Cited by 98
Park, S., Kim, J., Chun, J., Han, K., Soh, H., Kang, E. A., Lee, H. J., Im, J. P., & Kim, J. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081191 · Cited by 98
Beach, T. G., Corbillé, A.-G., Letournel, F., Kordower, J. H., Kremer, T., Munoz, D. G., Intorcia, A., Hentz, J., Adler, C. H., Sue, L. I., et al. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160888 · Cited by 96
Chauhan, V. S., Sterka, D. G., Furr, S. R., Young, A. B., & Marriott, I. (2009) · Glia · doi:10.1002/glia.20770 · Cited by 95
THE ASSOCIATION OF GASTRO‐DUODENAL ULCERATION AND PARKINSON'S DISEASE
Strang, R. R. (1965) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb72277.x · Cited by 94
Venezia, S., Refolo, V., Polissidis, A., Stefanis, L., Wenning, G. K., & Stefanova, N. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0195-7 · Cited by 91
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation
Gilsbach, B. K., & Kortholt, A. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00032 · Cited by 83
Sterka, D., Rati, D. M., & Marriott, I. (2006) · Glia · doi:10.1002/glia.20286 · Cited by 83
LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
Lee, H., James, W. S., & Cowley, S. A. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160262 · Cited by 82
CARD15 variants in patients with sporadic Parkinson’s disease
Bialecka, M., Kurzawski, M., Klodowska-Duda, G., Opala, G., Juzwiak, S., Kurzawski, G., Tan, E.-K., & Drozdzik, M. (2007) · Neuroscience Research · doi:10.1016/j.neures.2006.11.012 · Cited by 79
NOD2/CARD15 gene polymorphisms in Crohn's disease
Heresbach, D., Gicquel-Douabin, V. R., Birebent, B., D’Halluin, P. N., Berre, N. H.-L., Dréano, S., Siproudhis, L., Dabadie, A., Gosselin, M., Mosser, J., et al. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200401000-00009 · Cited by 74
Corbillé, A.-G., Letournel, F., Kordower, J. H., Lee, J., Shanes, E., Neunlist, M., Munoz, D. G., Derkinderen, P., & Beach, T. G. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0305-8 · Cited by 74
Zhao, M., & Burisch, J. M. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05648-w · Cited by 66
Gut Feelings Ab out α‐Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?
Ruffmann, C., & Parkkinen, L. (2016) · Movement Disorders · doi:10.1002/mds.26480 · Cited by 59
Côté, M., Poirier, A.-A., Aubé, B., Jobin, C., Lacroix, S., & Soulet, D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.009 · Cited by 58
Labrie, V., & Brundin, P. (2017) · Journal of Innate Immunity · doi:10.1159/000479653 · Cited by 57
Enteric alpha-synuclein expression is increased in Crohn’s disease
Prigent, A., Lionnet, A., Durieu, E., Chapelet, G., Bourreille, A., Neunlist, M., Rolli-Derkinderen, M., & Derkinderen, P. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1943-7 · Cited by 57
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Soto, M. S., Delgado‐Cortés, M. J., et al. (2011) · Parkinson s Disease · doi:10.4061/2011/393769 · Cited by 56
Alpha-synuclein immunoreactivity patterns in the enteric nervous system
Aldecoa, I., Navarro‐Otano, J., Stefanova, N., Sprenger, F., Seppi, K., Poewe, W. H., Cuatrecasas, M., Valldeoriola, F., Gelpí, E., & Tolosa, E. S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.07.005 · Cited by 52
Alpha-Synuclein, a Novel Viral Restriction Factor Hiding in Plain Sight
Massey, A. R., & Beckham, J. D. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3488 · Cited by 50
Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates
Resnikoff, H., Metzger, J. M., Lopez, M., Bondarenko, V., Mejia, A., Simmons, H. A., & Emborg, M. E. (2019) · Journal of Inflammation Research · doi:10.2147/jir.s196552 · Cited by 42 · cited 2×
“Marmosets with colitis had significantly increased expression of inflammatory markers and p- -syn, and decreased expression of -syn in the colonic myenteric ganglia [89].”
BackgroundMamais, A., Manzoni, C., Nazish, I., Arber, C., Sonustun, B., Wray, S., Warner, T. T., Cookson, M. R., Lewis, P. A., & Bandopadhyay, R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.023 · Cited by 40
Beynon, V., Cotofana, S., Brand, S., Lohse, P., Mair, A., Wagner, S., Mussack, T., Ochsenkühn, T., Folwaczny, M., Folwaczny, C., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20441 · Cited by 39
Genetic variants associated with Crohn's disease
Michail, S. K., Bultron, & DePaolo, R. W. (2013) · The Application of Clinical Genetics · doi:10.2147/tacg.s33966 · Cited by 34
LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease
Xiong, Y., Dawson, V. L., & Dawson, T. M. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120093 · Cited by 31
Comparison of Fecal Inflammatory Markers in Crohnʼs Disease
Wright, E. K., Kamm, M. A., Cruz, P. P. D., Hamilton, A. L., Ritchie, K. J., Keenan, J. I., Leach, S. T., Burgess, L. A., Aitchison, A., Gorelik, A., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000671 · Cited by 30
Occurrence of Crohn's disease with Parkinson’s disease
Fujioka, S., Curry, S., Kennelly, K. D., Tacik, P. M., Heckman, M. G., Tsuboi, Y., Strongosky, A. J., van Gerpen, J. A., Uitti, R. J., Ross, O. A., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.01.013 · Cited by 30
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3326 · Cited by 26
Ríos, J. P., Madrid-Navarro, C. J., Navarro, M., Tapia, M. J. C., Vera, M. J. P., Arillo, V. M. C., García, M. R. G., Mínguez‐Castellanos, A., & Sevilla, F. E. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025574 · Cited by 25
Gil-Martínez, A. L., Estrada, C. M., Cuenca‐Bermejo, L., Cano, J. A., Valiente, M., Martínez, C. M., Fernández‐Villalba, E., & Herrero, M. T. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0010-z · Cited by 15
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathologyPreprint
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/505164 · Cited by 14
Authors’ response: Association between IBD and Parkinson’s disease: seek and you shall find?
Villumsen, M., Aznar, S., Pakkenberg, B., Brudek, T., & Jess, T. (2018) · Gut · doi:10.1136/gutjnl-2018-317336 · Cited by 10
Self-citation
Research works printed but not linked: 5
- Machado A, 2011, Adv Neurol, 2011, 393769
- Villumsen M, 2018, Gut, 68, 1722
- Grathwohl S, 2019, bioRxiv, 505164
- Carabotti M, 2015, Ann Gastroenterol, 28, 203
- Berge N, 2019, Acta Neuropathol
Cited by
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero-Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 272
The Association Between the Gut Microbiota and Parkinson’s Disease, a Meta-Analysis
Shen, T., Yue, Y., He, T., Huang, C., Qu, B., Lv, W., & Lai, H.-Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.636545 · Cited by 219
“Higher susceptibility to PD was observed when intestinal infection existed (Huang et al., 2018; Brudek, 2019), which might trigger PD-like symptoms (Matheoud et al.”
BackgroundParkinson's Disease: A Multisystem Disorder
Costa, H. N., Esteves, A. R., Empadinhas, N., & Cardoso, S. M. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00934-6 · Cited by 181
Metadata
- Authors
- Brudek, T.
- Affiliations
- Frederiksberg Hospital (DK)
- Corresponding author
- Brudek, Tomasz
- ORCID
- Brudek, Tomasz
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2019-10-08
- Volume
- 9
- Issue
- s2
- Pages
- S331-S344
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC6839501
- OpenAlex
- W2980273606
- Cited by
- 139
- References
- 142
- Citations by year
- 2026: 6 · 2025: 23 · 2024: 21 · 2023: 17 · 2022: 32 · 2021: 31 · 2020: 8 · 2019: 1
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, inflammatory bowel disease, gut-brain axis, alpha-synuclein, Lewy bodies, dopaminergic neuron loss, intestinal inflammation, gut microbiota, glial activation, inflammatory cytokines, intestinal infection, IBD treatment, disease risk
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Parkinson Disease, Inflammatory Bowel Diseases, Enteric Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.